[Serotype distribution and antimicrobial resistance rates of Shigella spp. isolates in Tehran, Iran]

Siavosh Salmanzadeh-Ahrabi1, Siavosh Salmanzdeh-Ahrabi, Fereshteh Jafari

  • 1Department of Microbiology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran. salmanzadeh1@yahoo.com

Mikrobiyoloji Bulteni
|October 16, 2007
PubMed

Insights

Shigella sonnei and Shigella flexneri are common causes of diarrhea in Tehran. High resistance to common antibiotics like tetracycline and trimethoprim-sulphamethoxazole was observed, with cefixime and nalidixic acid showing lower resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Context:

  • Diarrheal diseases pose a significant public health challenge, particularly in urban settings.
  • Shigella species are a primary cause of bacterial dysentery worldwide, with varying antimicrobial resistance patterns.
  • Understanding local resistance trends is crucial for effective treatment strategies in regions like Tehran.

Purpose:

  • To investigate the antimicrobial resistance patterns and serotype distribution of Shigella species isolated from diarrheal patients in Tehran.
  • To determine the prevalence of different Shigella serotypes, including S. sonnei and S. flexneri.
  • To assess the susceptibility of Shigella isolates to various commonly used and newer antibiotics.

Summary:

  • A study of 1350 diarrheal patients in Tehran revealed an 11.5% Shigella isolation rate.
  • Shigella sonnei (55.1%) and S. flexneri (30.8%) were the predominant serotypes.
  • High resistance was noted for tetracycline (98.7%) and trimethoprim-sulphamethoxazole (93.6%), while cefixime (5.1%) and nalidixic acid (2.6%) showed low resistance. All isolates were susceptible to ceftriaxone and ciprofloxacin.

Impact:

  • Provides essential data for clinicians in Tehran to guide empirical antibiotic therapy for Shigella infections.
  • Highlights the urgent need for antimicrobial stewardship and surveillance programs to combat rising resistance.
  • Informs public health policies regarding the control and management of diarrheal diseases caused by Shigella.